Article
Dr. Patel explains the metrics tracked at Carolina Blood and Cancer Care and identifies how these informed their understanding of patient care.
Dr Sanjula Jain: US Health Care Spending “Defies Laws of Economics”
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
Sarcoma Care: Biomarker Advancements Shape the Future